Survival Outcomes of Patients with Primary Plasma Cell Leukemia in the Era of Proteasome Inhibitors and Immunomodulatory Agents: A Real-Life Multicenter Analysis
In this study, as in previous similar studies, we could not see an increased survival trend in pPCL, which is observed in MM. New studies are needed for pPCL, which is likely to increase with new diagnostic criteria, based on current agents and information from MM.
Authors
- Senem Maral (ORCID: https://orcid.org/0000-0003-4766-1861)
- Fevzi Altuntaş
- Orhan Kemal Yücel (ORCID: https://orcid.org/0000-0002-0455-1382)
- Ayfer Gedük (ORCID: https://orcid.org/0000-0001-9556-8915)
- Sema Seçilmiş (ORCID: https://orcid.org/0000-0003-2957-2339)
- Burak Devecı (ORCID: https://orcid.org/0000-0001-5820-1903)
- Zahit Bolaman
- İrfan Yavaşoğlu (ORCID: https://orcid.org/0000-0003-1703-2175)
- Vedat Aslan (ORCID: https://orcid.org/0000-0002-0281-912X)
- Tayfur Toptaş (ORCID: https://orcid.org/0000-0002-2690-8581)
- Ünal Ataş (ORCID: https://orcid.org/0000-0001-5897-6514)
- Hayri Oğul (ORCID: https://orcid.org/0000-0001-5989-3729)
- İbrahim Ethem Pınar (ORCID: https://orcid.org/0000-0001-9907-1498)
- Anıl Tombak (ORCID: https://orcid.org/0000-0002-7195-1845)
- Erdal Kurtoğlu (ORCID: https://orcid.org/0000-0002-6867-6053)
- Melda Cömert (ORCID: https://orcid.org/0000-0002-3554-7941)
- Fahir Özkalemkaş (ORCID: https://orcid.org/0000-0001-9710-134X)
- Tülin Tuğlular
- Sıdıka Gülkan Özkan (ORCID: https://orcid.org/0000-0001-5917-8071)
- Eren Gündüz
- Volkan Karakuş (ORCID: https://orcid.org/0000-0001-9178-2850)
- Murat Yıldırım (ORCID: https://orcid.org/0000-0001-6416-9575)
- Özen Dedeoğlu
- Nil Güler (ORCID: https://orcid.org/0000-0003-0604-6475)
- Ömür Gökmen Sevindik (ORCID: https://orcid.org/0000-0001-9636-4113)
- İlhami Berber (ORCID: https://orcid.org/0000-0003-3312-8476)
- Ahmet Kürşad Güneş (ORCID: https://orcid.org/0000-0001-5522-8342)
- Ahmet Sarıcı (ORCID: https://orcid.org/0000-0002-5916-0119)
- Serhat Çelik (ORCID: https://orcid.org/0000-0002-1052-9800)
- Utku İltar (ORCID: https://orcid.org/0000-0001-7129-418X)
- Fatih Yaman (ORCID: https://orcid.org/0000-0002-0494-571X)
- Meltem Aylı (ORCID: https://orcid.org/0000-0001-5766-5642)
- Sedanur Karaman Gülsaran (ORCID: https://orcid.org/0000-0002-1565-3341)
- Muzaffer Keklık (ORCID: https://orcid.org/0000-0002-6426-5249)
- Aliihsan Gemici (ORCID: https://orcid.org/0000-0002-3385-8359)
- Özgür Mehtap (ORCID: https://orcid.org/0000-0002-5603-1178)
- Levent Ündar (ORCID: https://orcid.org/0000-0002-9853-5075)
- Ozan Salim (ORCID: https://orcid.org/0000-0001-6687-0189)
- Rabin Saba (ORCID: https://orcid.org/0000-0002-4535-2363)
- Hakki Onur Kirgizlar
- Aydan Eroğlu (ORCID: https://orcid.org/0000-0003-0809-7313)
- Murat Albayrak
- Turgay Ulaş
- Hasan Atilla Özkan
- Mehmet Sinan Dal
Institutions
- Yeditepe University (TR)
- Trakya University (TR)
- Bursa Uludağ Üni̇versi̇tesi̇ (TR)
- University of Health Science (KH)
- Akdeniz University (TR)
- Inonu University (TR)
- Istanbul Medipol University (TR)
- Memorial Ankara Hospital (TR)
- Antalya Bilim University (TR)
- Ankara Onkoloji Eğitim ve Araştırma Hastanesi (TR)
- Antalya Eğitim ve Araştırma Hastanesi (TR)
- Sağlık Bilimleri Üniversitesi (TR)
- Dışkapı Yıldırım Beyazıt Eğitim ve Araştırma Hastanesi (TR)
- Pamukkale University (TR)
- Eskişehir Osmangazi University (TR)
- Mersin Üniversitesi (TR)
- Kocaeli Üniversitesi (TR)
- Marmara University (TR)
- Adnan Menderes University (TR)
- University of Health Sciences Antigua (AG)
- Erciyes University (TR)
Publication Details
- Journal
- Turkish Journal of Hematology
- Published
- 2024-11-06
- DOI
- https://doi.org/10.4274/tjh.galenos.2024.2024.0450
- Citations
- 1
- Primary Topic
- Chronic Lymphocytic Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.44